Novel Therapies for the Treatment of Newly Diagnosed Multiple Myeloma
 | Novel Therapies for the Treatment of Newly Diagnosed Multiple Myeloma CME, CPE Shaji K. Kumar, MD | |
| Release Date: June 27, 2018 Expiration Date: June 27, 2019 | ||
When managing newly diagnosed multiple myeloma (MM) patients, recommended diagnostic and treatment strategies are critical for optimizing outcomes. This activity will address how upfront testing strategies and current risk stratification processes support the identification of treatments that are tailored to each patient’s unique characteristics and needs. Provided by MediCom Worldwide, Inc.This activity is supported by educational grants from Amgen, Bristol-Myers Squibb, Celgene Corporation, and Takeda Oncology | ||
| Begin, Earn CreditView Only, No Credit | ||